Audit: Lynda Chin's abandoned $62 million IBM Watson collaboration didn't follow standard procedures

By Paul Goldberg and Matthew Bin Han Ong

An audit of an abandoned mega-project run by IBM Watson and MD Anderson Cancer Center found that the Houston-based institution skirted the UT System's procurement regulations as it spent $62.1 million on an ill-fated artificial intelligence system.

Is it research or run-of-the-mill IT?

Guest Editorial

The AACI Network Care Initiative

By Stanton Gerson

Recent Issues

Audit: Lynda Chin's abandoned $62 million IBM Watson collaboration didn't follow standard procedures

Is it research or run-of-the-mill IT?

The AACI Network Care Initiative

In Brief

Salk scientist awarded $500K Swedish prize

Prostate Cancer Foundation awards $8.6 million to eight teams

U.S. Preventive Services Task Force appoints three new members

BTG and Society of Interventional Oncology to explore role of minimally invasive therapies in immuno-oncology

Perthera, Hope for Stomach Cancer to provide patient services

RPRD Diagnostics, Children's Minnesota to advance clinical pharmacogenomics

Jeffery Kutok named chief scientific officer at Infinity

CVS Health earns CEO Cancer Gold Standard accreditation

Funding Opportunities

PCRP announces research awards application guidelines

Drugs & Targets

Amgen submits Supplemental Biologics License Application for Blincyto

Pan-Canadian Pharmaceutical Alliance, BMS reach agreement on Opdivo

Immunomedics enters into licensing agreement with Seattle Genetics for Sacituzumab Govitecan

Recent Issues

Renew today!

Subscriber content